Summary
The synthesis of adenosine triphosphate (ATP) depends on the coordinated interaction of oxygen delivery and glucose breakdown in the Krebs cycle. Cellular oxygen depots are non-existent, therefore the peripheral cells are totally dependent on the circulation for sufficient oxygen delivery. Shock is the clinical manifestation of cellular oxygen craving. The commonly measured variables — blood pressure, heart rate, urinary output, cardiac output and systemic vascular resistance — are not sensitive or accurate enough to warn of impending death in acutely ill patients nor are they appropriate for monitoring therapy. Calculated oxygen transport and oxygen consumption parameters provide the best available measures of functional adequacy of both circulation and metabolism.
In order to optimise oxygen delivery (DO2), 4 interacting factors must be taken into account: cardiac output, blood haemoglobin content, haemoglobin oxygen saturation and avidity of oxygen binding to haemoglobin. For viscosity reasons, the optimal haemoglobin concentration is in the vicinity of 90 to 100 g/L, but for optimising the oxygen transport 100 to 115 g/L or a haematocrit of 30 to 35% seems better. The p50 (the pO2 at which haemoglobin is 50% saturated) describes the oxygen-haemoglobin dissociation curve; normally its value is ± 27mm Hg. It can be influenced by attaining normal body temperature, pH, pCO2 and serum phosphorous levels. In order to obtain an arterial blood saturation (SaO2) of more than 90% with acceptable haemodynamics, the ventilation mode and inspired oxygen fraction (FiO2) must be adapted; care must be taken not to stress the labile circulation with haemodynamic compromising ventilation techniques [e.g. high positive end expiratory pressure (PEEP) levels, inverse-ratio ventilation, etc.].
The factor most amenable to manipulation is the cardiac output, with its 4 determinants — preload, afterload, contractility and heart rate. In daily clinical practice, heart rate should be between 80 and 120 beats/min; small variations are acceptable. Important deviations must be treated by chemically [isoprenaline (isoproterenol)] or electrically (pacing techniques) accelerating the heart, or with the different antiarrhythmic drugs. A wide variety of agents is available to decrease the preload: diuretics [especially furosemide (frusemide)], venodilators like nitroglycerin (glyceryl trinitrate), isosorbide dinitrate (sorbide nitrate) and sodium nitroprusside, ACE inhibitors, phlebotomy, and haemofiltration techniques (peritoneal or haemodialysis, continuous arteriovenous haemofiltration). To increase the preload, volume loading using a rigid protocol (‘rule of 7 and 3’), preferably with colloids, or vasopressor agents [norepinephrine (noradrenaline), epinephrine (adrenaline), dopamine] are useful. Arterial vasopressors are needed to improve perfusion pressure of ‘critical’ (coronary and cerebral) arteries. Afterload can be decreased by arterial vasodilators. Predominantly arterial dilators are hydralazine and clonidine, while sodium nitroprusside, nitroglycerin and isosorbide dinitrate have combined arterial and venous dilating actions. Norepinephrine, epinephrine and dopamine combine inotropic with vasoconstricting properties; dobutamine, dopexamine and the phosphodiesterase inhibitors amrinone, milrinone and enoximone are combined positive inotropic and afterload reducing drugs. The phosphodiesterase inhibitors possess lusitropic (i.e. promoting myocardial relaxation) effects. Myocardial oxygen consumption is certainly increased by norepinephrine, epinephrine, isoprenaline and dopamine, while dobutamine only has minimal effects and the phosphodiesterase inhibitors lower it.
To treat a critically ill patient according to the abovementioned strategy, the intensive care physician must rely on invasive haemodynamic measurements. Several derived parameters, all critically dependent on a correct determination of the cardiac output, give insight into pathophysiological process; they are also necessary to guide sometimes complex pharmacological manipulations in order to maximise oxygen delivery and consumption.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
ACC/AHA Task Force. ACC/AHA guidelines for the early management of patients with acute myocardial infarction. Circulation 82: 664–707, 1990
Baker C, Wilmoth F. Microvascular responses to E-coli endotoxin with altered adrenergic activity. Circulatory Shock 12: 165, 1984
Bode V, Welzel D, Franz G, Polensky U. Absence of drug interaction between heparin and nitroglycerin. Archives of Internal Medicine 150: 2117–2119, 1990
Breuer H-WM, Groeben H, Breuer J, Worth H. Oxygen saturation calculation procedures: a critical analysis of six equations for the determination of oxygen saturation. Intensive Care Medicine 15: 385–389, 1989
Bryan-Brown CW. Blood flow to organs: parameters for function and survival in critical illness. Critical Care Medicine 16: 170–178, 1988
Cigarroa RG, Lange RA, Williams RH, Bedotto JB, Hillis D. Underestimation of cardiac output by thermodilution in patients with tricuspid regurgitation. American Journal of Medicine 86: 417–420, 1989
Cope DK, Allison RC, Parmentier JL, Miller JM, Taylor AE. Measurement of effective pulmonary capillary pressure using the pressure profile after pulmonary artery occlusion. Critical Care Medicine 14: 16–22, 1986
Daily EK, Schroeder JS. Techniques in bedside hemodynamic monitoring, The CV Mosby Company, St Louis, Toronto, London, 1981
Dash H, Lipton MJ, Chatterjee K, Parmley WW. Estimation of pulmonary artery wedge pressure from chest radiograph in patients with chronic congestive cardiomyopathy and ischemic myopathy. British Heart Journal 44: 322–329, 1980
Deedmania PC. Antiotensin-converting enzyme inhibition in congestive heart failure. Archives of Internal Medicine 150: 1798–1805, 1990
Demey HE, Daelemans RA, Verpooten GA, De Broe ME, Van Campenhout CM, et al. Propylene glycol induced side effects during intravenous nitrogycerin therapy. Intensive Care Medicine 14: 221–226, 1984
Dhainaut JF, Edwards JD. Grootendorst AF, Nightingale P, Pinsky MR, et al. Practical aspects of oxygen transport: conclusions and recommendations of the roundtable conference. Intensive Care Medicine 16 (Suppl. 2) S179–S180, 1990
Edwards JD. Practical application of oxygen transport principles. Critical Care Medicine 18:S45–S481990
Edwards JD, Brown GCS, Nightingale P, Slater RM, Faragher EB. Use of survivors’ cardiorespiratory values as therapeutic goals in septic shock. Critical Care Medicine 17: 1098–1103, 1989
Eisenberg PR, Jatte AS, Shuster DP. Clinical evaluation compared to pulmonary artery catheterisation in the haemodynamic assessment of critically ill patients. Critical Care Medicine 12: 549–553, 1984
Fein AM, Goldberg SK, Walkenstein MD, Dershaw B, Braitman L, et al. Is pulmonary artery catheterisation necessary for the diagnosis of pulmonary edema? American Review of Respiratory Diseases 129: 1006–1009, 19
Forrester J, Diamond G, Chatterjee K, Swan H. Medical therapy of acute infarction by application of hemodynamic subsets. New England Journal of Medicine 295: 1356–1362, 1404–1413, 1976
Friesinger GCI, Williams SV. Clinical competence in hemodynamic monitoring: a statement for physicians from the ACP/ ACC/AHA task force on clinical privileges in cardiology. Circulation 81: 2036–2040, 1990
Gardner RM. Direct blood pressure measurement — dynamic response requirements. Anesthesiology 54: 227–236, 1981
Giovannini I, Chiarla C, Siegel JH, Coleman WP. A simple method for rapid estimate of P50. 9th International Symposium on Intensive Care and Emergency Medicine, Brussels, 1989
Goethals M, Demey H. Massive dobutamine overdose in a cardiovascular compromised patient. Acta Cardiologica 39: 373–378, 1984
Habbab MA, Haft JI. Heparin resistance induced by intravenous nitroglycerin. Archives of Internal Medicine 147: 857–860, 1987
Hamilton MA, Stevenson LW, Woo M, Child JS, Tillisch JH. Effect of tricuspid regurgitation on the reliability of the thermodilution cardiac output technique in congestive heart failure. American Journal of Cardiology 64: 945–948, 1989
Hartzler GO, Maloney JD, Curtis JJ, Barnhorst DA. Hemodynamic benefit of atrioventricular sequential pacing after cardiac surgery. American Journal of Cardiology 40: 232–236, 1977
Haude M, Steffen W, Erbel R, Meyer J. Sublingual administration of captopril versus nitroglycerin in patients with severe congestive heart failure. International Journal of Cardiology 27: 351–359, 1990
Haude M, Steffen W, Erbel R, Tschollar W, Belz GG, et al. Hemodynamics after sublingual administration of captopril in severe heart failure: a pilot study. Deutsche Medizinische Wochenschrift 114: 1095–1100, 1989
Hesselvik J, Brodin B. Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow and oxygen transport. Critícal Care Medicine 17: 179, 1989
Hillman K. Colloid versus crystalloid fluid therapy in the critically ill. Intensive and Critical Care Digest 5: 7–9, 1986
Holloway H, Perry M, Downey J, Parker J, Taylor A. Estimation of effective pulmonary capillary pressure in intact lungs. Journal of Applied Physiology 54: 846–851, 1983
Kimchi A, Ellrodt A, Bermand D. Right ventricular performance in septic shock: a combined radionuclide and hemodynamic study. Journal of the American College of Cardiology 4: 945, 1984
Klotz U, Kroemer H. Clinical pharmacokinetic considerations in the use of plasma expanders. Clinical Pharmacokinetics 12: 123–135, 1987
Kraus PA, Lipmen J, Becker PJ. Acute preload effects of furosemide. Chest 98: 124–128, 1990
Laine GA. Pulmonary capillary pressure? Critical Care Medicine 14: 76–77, 1986
Marcus FI, Opie LH, Sonnenblick EH. Digitalis and sympathomimetic stimulants. In Opie LH (Ed.) Drugs for the heart, pp. 99–128, Grune & Stratton Inc, Orlando, San Diego, San Francisco, New York, London, Toronto, Montreal, Sydney, Tokyo, Sao Paulo, 1983
Morris AH, Chapman RH, Gardner RM. Frequency of wedge pressure errors in the ICU. Critical Care Medicine 13: 705–708, 1985
Narins RG, Chusid P. Diuretic use in critical care. American Journal of Cardiology 57: 26A-32A, 1986
Nightingale P. Practical points in the application of oxygen transport principles. Intensive Care Medicine 16 (Suppl. 2): S173–S177, 1990
Ohar JM, Fowler AA, Selhorst JB, Glauser FL. Intravenous nitroglycerin induced intracranial hypertension. Critical Care Medicine 13: 867, 1985
Pansard J, Desmonts J. New techniques in ICU cardiorespiratory monitoring. Current Opinion in Anaesthesiology 2: 169–172, 1989
Parker M, Shelhamer J, Bacharach S. Profound but reversible myocardial depression in patients with septic shock. Annals of Internal Medicine 100: 483, 1984
Parrillo J (Moderator). Septic shock in humans: advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Annals of Internal Medicine 113: 227–242, 1990
Parrillo JE. Vasodilator therapy. In Chernow & Lake (Eds) The pharmacologic approach to the critically ill patient, pp. 283–302, Williams and Wilkins, Baltimore, London, 1983
Pichard A, Diaz R, Marchant E, Casanegra P. Large v waves in the pulmonary capillary wedge pressure tracing, without mitral regurgitation: the influence of the pressure/volume relationship on the v wave size. Clinical Cardiology 6: 534–541, 1983
Pinsky MR, Schlichtig R. Regional oxygen delivery in oxygen supply-dependent states. Intensive Care Medicine 16 (Suppl. 2): S169–S171, 1990
Raper R, Sibbald WJ. Misled by the wedge? The Swan-Ganz catheter and left ventricular preload. Chest 89: 427–434, 1986
Räsänen J. Role of dual oximetry in the assessment of pulmonary function. In Reinhart & Eyrich (Eds) Clinical aspects of O2transport and tissue oxygenation, pp. 230–240, Springer-Verlag, Berlin, Heidelberg, New York, London, Paris, Tokyo, Hong Kong, 1989
Rinkenberger RL, Nacarrelli GV. Evaluation and acute treatment of wide complex tachycardias. Critical Care Clinics 5: 569–598, 1989
Rinkenberger RL, Nacarrelli GV. Evaluation and treatment of narrow complex tachycardias. Critical Care Clinics 5: 599–642, 1989
Robin ER. The cult of the Swan-Ganz catheter: overuse and abuse of pulmonary flow catheters. Annals of Internal Medicine 103: 445–449, 1985
Sharkey SW. Beyond the wedge: clinical physiology and the Swan-Ganz catheter. American Journal of Medicine 83: 111–122, 1987
Shoemaker W. Relation of oxygen transport patterns to the pathophysiology and therapy of shock states. Intensive Care Medicine 13: 230–243, 1987
Shoemaker WC. Shock states: pathophysiology, monitoring, outcome, prediction, and therapy. In Shoemaker et al. (Eds) Textbook of critical care pp. 977–993, WB Saunder Company, Philadelphia, London, Toronto, Montreal, Sydney, Tokyo, 1989
Shoemaker WC, Kram HB, Appel PL. Therapy of shock based on pathophysiology, monitoring and outcome prediction. Critical Care Medicine 18: S19–S25, 1990
Simoons M, Demey H, Bossaert L, Colardyn F, Essed C. The Paceport catheter: a new pacemaker system introduced through a Swan Ganz catheter. Catheterization and Cardiovascular Diagnosis 15: 66–70, 1988
Stevens J, Raffin T, Mihm F. Thermodilution cardiac output measurement: effects of the respiratory cycle on its reproducibility. Journal of the American Medical Association 253: 2240–2242, 1985
Teboul XL, Zapol WM, Brun-Buisson C, Abrouk F, Rauss A, et al. A comparison of pulmonary artery occluded pressure and left ventricular end-diastolic pressure during mechanical ventilation with PEEP in patients with severe ARDS. Anesthesiology 70: 261–266, 1989
Tuman KJ, Carroll GC, Ivankovich AD. Pitfalls in interpretation of pulmonary artery data. Journal of Cardiothoracic Anesthesia 3: 625–641, 1989
Twigley A, Hillman K. The end of the crystalloid era? A new approach to perioperative fluid administration. Anaesthesia 40: 860–871, 1985
Vincent J-L. The pulmonary artery catheter: twenty years of use. Clinical Intensive Care 1: 244–248, 1990
West JB, Dollery CT, Naimark A. Distribution of blood flow in isolated lung; relation to vascular and alveolar pressures. Journal of Applied Physiology 19: 713–724, 1964
Wiedemann HP, Matthay MA, Matthay RA. Cardiovascular-pulmonary monitoring in the intensive care unit (part I). Chest 85: 537–549, 1984
Wiedemann HP, Matthay MA, Matthay RA. Cardiovascular-pulmonary monitoring in the intensive care unit (part 2). Chest 85: 656–668, 1984
Wynands JE. Amrinpne: is it the inotrope of choice? Journal of Cardiovascular Anesthesia 6: 45–47, 1989
Zadrobilek E, Hackl W, Sporn P, Steinbereithner K. Effect of large volume replacement with balanced electrolyte solutions on extravascular lung water in surgical patients with sepsis syndrome. Intensive Care Medicine 15: 505–510, 1989
Zaloga P, Chernow B. Insulin, glucagon and growth hormone. In Chernow & Lake (Eds) The pharmacologic approach to the critically ill patient, pp. 562–585, Williams and Wilkins, Baltimore, London, 1983
Zaritsky AL, Chernow B. Catecholamines, sympathomimetics. In Chernow & Lake (Eds) The pharmacologic approach to the critically ill patient, pp. 481–509, Williams & Wilkins, Baltimore, London, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bossaert, L.L., Demey, H.E., De Jongh, R. et al. Haemodynamic Monitoring. Drugs 41, 857–874 (1991). https://doi.org/10.2165/00003495-199141060-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199141060-00004